[Federal Register Volume 75, Number 200 (Monday, October 18, 2010)]
[Notices]
[Page 63845]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2010-26253]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA-2010-N-0389]
Medical Device User Fees; Public Meeting; Extension of Comment
Period
AGENCY: Food and Drug Administration, HHS.
ACTION: Notice; extension of comment period.
-----------------------------------------------------------------------
SUMMARY: The Food and Drug Administration (FDA) is extending to
November 1, 2010, the comment period for the notice that appeared in
the Federal Register of August 13, 2010 (75 FR 49502). In the notice,
FDA requested input and comments from interested stakeholders on the
Agency's medical user fee program and requested suggestions regarding
the commitments FDA should propose for the next reauthorized program.
The Agency is taking this action to allow interested persons additional
time to submit comments.
DATES: Submit either electronic or written comments and information by
November 1, 2010.
ADDRESSES: Submit electronic comments to http://www.regulations.gov.
Submit written comments to the Division of Dockets Management (HFA-
305), Food and Drug Administration, 5630 Fishers Lane, rm. 1061,
Rockville, MD 20852. To ensure consideration, all comments must be
received by November 1, 2010. Identify comments with the docket number
found in brackets in the heading of this document.
FOR FURTHER INFORMATION CONTACT: James Swink, Center for Devices and
Radiological Health, Food and Drug Administration, 10903 New Hampshire
Ave., Bldg. 66, rm. 1609, Silver Spring, MD 20993-0002, 301-796-6313,
FAX: 301-847-8121, e-mail: [email protected].
SUPPLEMENTARY INFORMATION:
I. Background
In the Federal Register of August 13, 2010 (75 FR 49502), FDA
published a notice announcing a public meeting on September 14, 2010,
and the opening of a public docket to seek input and comments from
interested stakeholders to discuss the Agency's medical user fee
program and requested suggestions regarding the commitments FDA should
propose for the next reauthorized program. Interested persons were
invited to submit comments to the public docket by October 14, 2010. At
this time, the Agency is announcing its intention to post the
transcript of the September 14, 2010, public meeting and is extending
the comment period until November 1, 2010, to continue to receive
public comments.
II. Request for Comments
Interested persons may submit to the Division of Dockets Management
(see ADDRESSES) either electronic or written comments regarding this
document. It is only necessary to send one set of comments. It is no
longer necessary to send two copies of mailed comments. Identify
comments with the docket number found in brackets in the heading of
this document. Received comments may be seen in the Division of Dockets
Management between 9 a.m. and 4 p.m., Monday through Friday.
Dated: October 14, 2010.
Leslie Kux,
Acting Assistant Commissioner for Policy.
[FR Doc. 2010-26253 Filed 10-14-10; 4:15 pm]
BILLING CODE 4160-01-P